3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
1
Oligodendroglioma
1
Neoplasms
1
Glucose Metabolism Disorders
1
Glucose Intolerance
1
Glioblastoma
1
Fatty Liver
1
Astrocytoma
1
Interventions
Temozolomide
44
Radiotherapy
20
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Carboplatin
11
Bevacizumab
11
Filgrastim
9
Surgical Procedures, Operative
7
Procarbazine
6
sargramostim
5
Vincristine
5
Imatinib Mesylate
5
Etoposide
5
Erlotinib Hydrochloride
5
Carmustine
5
Biopsy
5
etoposide phosphate
4
Peripheral Blood Stem Cell Transplantation
4
Lomustine
4
Immunohistochemistry
4
Cyclophosphamide
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
temsirolimus
3
poly ICLC
3
aldesleukin
3
Thalidomide
3
Surveys and Questionnaires
3
Radiation
3
Polymerase Chain Reaction
3
Gadolinium DTPA
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Oligodendroglioma
×
Proton Magnetic Resonance Spectroscopy
×
Clear all
NCT00645385
2019-06-04
Gliadel-MRS
Weill Medical College of Cornell University
Withdrawn